Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Biotechnology

Editor-in-Chief

ISSN (Print): 1389-2010
ISSN (Online): 1873-4316

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Species Specificity on Interaction between IgE and FcεRI

Author(s): Xiangsheng Li, Nannan Wang, Yang Zhao, Yanfen Zhang* and Zhongcheng Liu*

Volume 20, Issue 9, 2019

Page: [690 - 695] Pages: 6

DOI: 10.2174/1389201020666190619122325

Price: $65

Abstract

Allergic diseases are one of the most prevalent diseases at present, it is imperative to understanding the pathophysiology and treatment strategies for allergic diseases. In this process, the binding of IgE and FcεRI on effector cells plays a critical role in triggering allergic reactions. However, the species specificity of the interaction between IgE and FcεRI has not been clearly explained. This review described the characteristics and the interaction mechanism in the allergic reaction of IgE and FcεRI and summarized the species specificity between IgE and FcεRI.

Keywords: Allergic disease, immunoglobulin E, FcεRI, species specificity, effector cells, receptor affinity.

« Previous Next »
Graphical Abstract

[1]
Deng, Z.; Pu, X.P. Progress in research of the targets and new drugs resisting type I hypersensitivity. Chin. J. New. Drug., 2013, 22(4), 417-446.
[2]
Castillo-Arellano, J.I.; Guzmán-Gutiérrez, S.L.; Ibarra-Sánchez, A.; Hernández-Ortega, S.; Nieto-Camacho, A.; Medina-Campos, O.N.; Pedraza-Chaverri, J.; Reyes-Chilpa, R.; González-Espinosa, C. Jacareubin inhibits FcεRI-induced extracellular calcium entry and production of reactive oxygen species required for anaphylactic degranulation of mast cells. Biochem. Pharmacol., 2018, 154, 344-356.
[http://dx.doi.org/10.1016/j.bcp.2018.05.002] [PMID: 29802828]
[3]
Yalcin, A.D. An overview of the effects of anti-IgE therapies. Med. Sci. Monit., 2014, 20, 1691-1699.
[http://dx.doi.org/10.12659/MSM.890137] [PMID: 25241913]
[4]
Liu, Z.C.; Shi, H.L.; Zhang, Y.F.; Zhao, L.J. [Progress in the study of allergic disease drugs targeting on IgE/FcepsilonRI signaling pathway]. Yao Xue Xue Bao, 2011, 46(10), 1161-1166.
[PMID: 22242444]
[5]
Smith, L.D.; Leatherbarrow, R.J.; Spivey, A.C. Development of small molecules to target the IgE:FcεRI protein-protein interaction in allergies. Future Med. Chem., 2013, 5(12), 1423-1435.
[http://dx.doi.org/10.4155/fmc.13.112] [PMID: 23919552]
[6]
Berings, M.; Gevaert, P.; De Ruyck, N.; Derycke, L.; Holtappels, G.; Pilette, C.; Bachert, C.; Lambrecht, B.N.; Dullaers, M. FcεRI expression and IgE binding by dendritic cells and basophils in allergic rhinitis and upon allergen immunotherapy. Clin. Exp. Allergy, 2018, 48(8), 970-980.
[http://dx.doi.org/10.1111/cea.13157] [PMID: 29682789]
[7]
Suzuki, R.; Scheffel, J.; Rivera, J. New insights on the signaling and function of the high-affinity receptor for IgE. Curr. Top. Microbiol. Immunol., 2015, 388, 63-90.
[http://dx.doi.org/10.1007/978-3-319-13725-4_4] [PMID: 25553795]
[8]
Ishizaka, K.; Ishizaka, T. Identification of gamma-E-antibodies as a carrier of reaginic activity. J. Immunol., 1967, 99(6), 1187-1198.
[PMID: 4168663]
[9]
Galli, S.J.; Tsai, M. IgE and mast cells in allergic disease. Nat. Med., 2012, 18(5), 693-704.
[http://dx.doi.org/10.1038/nm.2755] [PMID: 22561833]
[10]
Platts-Mills, T.A.E.; Schuyler, A.J.; Erwin, E.A.; Commins, S.P.; Woodfolk, J.A. IgE in the diagnosis and treatment of allergic disease. J. Allergy Clin. Immunol., 2016, 137(6), 1662-1670.
[http://dx.doi.org/10.1016/j.jaci.2016.04.010] [PMID: 27264001]
[11]
Ishizaka, K.; Ishizaka, T. Identification of IgE. J. Allergy Clin. Immunol., 2016, 137(6), 1646-1650.
[http://dx.doi.org/10.1016/j.jaci.2015.12.1343] [PMID: 27090936]
[12]
Johansson, S.G.O. The discovery of IgE. J. Allergy Clin. Immunol., 2016, 137(6), 1671-1673.
[http://dx.doi.org/10.1016/j.jaci.2016.04.004] [PMID: 27264002]
[13]
Hamilton, R.G.; MacGlashan, D.W., Jr; Saini, S.S. IgE antibody-specific activity in human allergic disease. Immunol. Res., 2010, 47(1-3), 273-284.
[http://dx.doi.org/10.1007/s12026-009-8160-3] [PMID: 20066506]
[14]
Bischoff, S.C. Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data. Nat. Rev. Immunol., 2007, 7(2), 93-104.
[http://dx.doi.org/10.1038/nri2018] [PMID: 17259966]
[15]
Wu, L.C.; Scheerens, H. Targeting IgE production in mice and humans. Curr. Opin. Immunol., 2014, 31, 8-15.
[http://dx.doi.org/10.1016/j.coi.2014.08.001] [PMID: 25156315]
[16]
Gould, H.J.; Sutton, B.J. IgE in allergy and asthma today. Nat. Rev. Immunol., 2008, 8(3), 205-217.
[http://dx.doi.org/10.1038/nri2273] [PMID: 18301424]
[17]
Wu, L.C.; Zarrin, A.A. The production and regulation of IgE by the immune system. Nat. Rev. Immunol., 2014, 14(4), 247-259.
[http://dx.doi.org/10.1038/nri3632] [PMID: 24625841]
[18]
Dhaliwal, B.; Yuan, D.; Pang, M.O.; Henry, A.J.; Cain, K.; Oxbrow, A.; Fabiane, S.M.; Beavil, A.J.; McDonnell, J.M.; Gould, H.J.; Sutton, B.J. Crystal structure of IgE bound to its B-cell receptor CD23 reveals a mechanism of reciprocal allosteric inhibition with high affinity receptor FcεRI. Proc. Natl. Acad. Sci. USA, 2012, 109(31), 12686-12691.
[http://dx.doi.org/10.1073/pnas.1207278109] [PMID: 22802656]
[19]
Sutton, B.J.; Davies, A.M. Structure and dynamics of IgE-receptor interactions: FcεRI and CD23/FcεRII. Immunol. Rev., 2015, 268(1), 222-235.
[http://dx.doi.org/10.1111/imr.12340] [PMID: 26497523]
[20]
Davies, A.M.; Allan, E.G.; Keeble, A.H.; Delgado, J.; Cossins, B.P.; Mitropoulou, A.N.; Pang, M.O.Y.; Ceska, T.; Beavil, A.J.; Craggs, G.; Westwood, M.; Henry, A.J.; McDonnell, J.M.; Sutton, B.J. Allosteric mechanism of action of the therapeutic anti-IgE antibody omalizumab. J. Biol. Chem., 2017, 292(24), 9975-9987.
[http://dx.doi.org/10.1074/jbc.M117.776476] [PMID: 28438838]
[21]
Reber, L.L.; Hernandez, J.D.; Galli, S.J. The pathophysiology of anaphylaxis. J. Allergy Clin. Immunol., 2017, 140(2), 335-348.
[http://dx.doi.org/10.1016/j.jaci.2017.06.003] [PMID: 28780941]
[22]
Kinet, J.P. The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology. Annu. Rev. Immunol., 1999, 17(1), 931-972.
[http://dx.doi.org/10.1146/annurev.immunol.17.1.931] [PMID: 10358778]
[23]
Gounni, A.S.; Lamkhioued, B.; Koussih, L.; Ra, C.; Renzi, P.M.; Hamid, Q. Human neutrophils express the high-affinity receptor for immunoglobulin E (Fc epsilon RI): role in asthma. FASEB J., 2001, 15(6), 940-949.
[http://dx.doi.org/10.1096/fj.00-0378com] [PMID: 11292654]
[24]
Dombrowicz, D.; Quatannens, B.; Papin, J.P.; Capron, A.; Capron, M. Expression of a functional Fc epsilon RI on rat eosinophils and macrophages. J. Immunol., 2000, 165(3), 1266-1271.
[http://dx.doi.org/10.4049/jimmunol.165.3.1266] [PMID: 10903725]
[25]
Zeng, H.R.; Wang, B.; Zhao, Z.; Zhang, Q.; Liang, M.Y.; Yao, Y.Q.; Bian, K.; Zhang, W.R. Effects of Viola yedoensis Makino anti-itching compound on degranulation and cytokine generation in RBL-2H3 mast cells. J. Ethnopharmacol., 2016, 189, 132-138.
[http://dx.doi.org/10.1016/j.jep.2016.05.030] [PMID: 27196296]
[26]
Gould, H.J.; Ramadani, F. IgE responses in mouse and man and the persistence of IgE memory. Trends Immunol., 2015, 36(1), 40-48.
[http://dx.doi.org/10.1016/j.it.2014.11.002] [PMID: 25499855]
[27]
Ravetch, J.V. Fc receptors. Curr. Opin. Immunol., 1997, 9(1), 121-125.
[http://dx.doi.org/10.1016/S0952-7915(97)80168-9] [PMID: 9039776]
[28]
Lin, S.; Cicala, C.; Scharenberg, A.M.; Kinet, J.P. The Fc(ε)RIbeta subunit functions as an amplifier of Fc(ε)RIgamma-mediated cell activation signals. Cell, 1996, 85(7), 985-995.
[http://dx.doi.org/10.1016/S0092-8674(00)81300-8] [PMID: 8674126]
[29]
Berings, M.; Gevaert, P.; De Ruyck, N.; Derycke, L.; Holtappels, G.; Pilette, C.; Bachert, C.; Lambrecht, B.N.; Dullaers, M. FcεRI expression and IgE binding by dendritic cells and basophils in allergic rhinitis and upon allergen immunotherapy. Clin. Exp. Allergy, 2018, 48(8), 970-980.
[http://dx.doi.org/10.1111/cea.13157] [PMID: 29682789]
[30]
Zellweger, F.; Gasser, P.; Brigger, D.; Buschor, P.; Vogel, M.; Eggel, A. A novel bispecific DARP in targeting FcγRIIB and FcεRI-bound IgE inhibits allergic responses. Allergy, 2017, 72(8), 1174-1183.
[http://dx.doi.org/10.1111/all.13109] [PMID: 27997998]
[31]
Balbino, B.; Conde, E.; Marichal, T.; Starkl, P.; Reber, L.L. Approaches to target IgE antibodies in allergic diseases. Pharmacol. Ther., 2018, 191, 50-64.
[http://dx.doi.org/10.1016/j.pharmthera.2018.05.015] [PMID: 29909239]
[32]
Weetall, M.; Shopes, B.; Holowka, D.; Baird, B. Mapping the site of interaction between murine IgE and its high affinity receptor with chimeric Ig. J. Immunol., 1990, 145(11), 3849-3854.
[PMID: 2147205]
[33]
Tang, H. Interaction between IgE and the high-affinity IgE receptor (FcεRI). J. Immunol., 2005, 21(3), 57-64.
[PMID: 16177098]
[34]
Wurzburg, B.A.; Jardetzky, T.S. Structural insights into the interactions between human IgE and its high affinity receptor FcepsilonRI. Mol. Immunol., 2002, 38(14), 1063-1072.
[http://dx.doi.org/10.1016/S0161-5890(02)00035-4] [PMID: 11955598]
[35]
Keown, M.B.; Ghirlando, R.; Mackay, G.A.; Sutton, B.J.; Gould, H.J. Basis of the 1:1 stoichiometry of the high affinity receptor Fc ε RI-IgE complex. Eur. Biophys. J., 1997, 25(5-6), 471-476.
[http://dx.doi.org/10.1007/s002490050062] [PMID: 9188170]
[36]
Hakimi, J.; Seals, C.; Kondas, J.A.; Pettine, L.; Danho, W.; Kochan, J. The alpha subunit of the human IgE receptor (FcERI) is sufficient for high affinity IgE binding. J. Biol. Chem., 1990, 265(36), 22079-22081.
[PMID: 2148316]
[37]
Blank, U.; Charles, N.; Benhamou, M. The high-affinity immunoglobulin E receptor as pharmacological target. Eur. J. Pharmacol., 2016, 778, 24-32.
[http://dx.doi.org/10.1016/j.ejphar.2015.05.070] [PMID: 26130123]
[38]
Ra, C.; Jouvin, M.H.; Kinet, J.P. Complete structure of the mouse mast cell receptor for IgE (Fc ε RI) and surface expression of chimeric receptors (rat-mouse-human) on transfected cells. J. Biol. Chem., 1989, 264(26), 15323-15327.
[PMID: 2527850]
[39]
Giavina-Bianchi, P.; Picard, M.; Caiado, J.; Mezzano, V.; Castells, M.C. LAMP1 and CD63 expression in mouse mast cells and human basophils rendered hyporesponsive by antigen/IgE-mediated activation and desensitization. J. Allergy Clin. Immunol., 2014, 133, AB59.
[http://dx.doi.org/10.1016/j.jaci.2013.12.235]
[40]
Plaut, M.; Lichtenstein, L.M.; Bloch, K.J. Failure to obtain histamine release from rat mast cells exposed to human allergic serum and specific antigen or IgE myeloma protein and anti-IgE. J. Immunol., 1973, 111(4), 1022-1030.
[PMID: 4125607]
[41]
Wang, N.N.; Liu, Z.C.; Zhang, Y.F.; Liu, Y.X.; Cui, Z.; Chen, Y. Construction and evaluation of hFcεRIα/RBL-2H3 cell strain. Chin. Pharmacol. Bull., 2015, 31(8), 1174-1179.
[42]
Takagi, K.; Nakamura, R.; Teshima, R.; Sawada, J. Application of human Fc ε RI α-chain-transfected RBL-2H3 cells for estimation of active serum IgE. Biol. Pharm. Bull., 2003, 26(2), 252-255.
[http://dx.doi.org/10.1248/bpb.26.252] [PMID: 12576689]
[43]
Taudou, G.; Varin-Blank, N.; Jouin, H.; Marchand, F.; Weyer, A.; Blank, U. Expression of the alpha chain of human Fc ε RI in transfected rat basophilic leukemia cells: functional activation after sensitization with human mite-specific IgE. Int. Arch. Allergy Immunol., 1993, 100(4), 344-350.
[http://dx.doi.org/10.1159/000236436] [PMID: 8481652]
[44]
Fung-Leung, W.P.; De Sousa-Hitzler, J.; Ishaque, A.; Zhou, L.; Pang, J.; Ngo, K.; Panakos, J.A.; Chourmouzis, E.; Liu, F.T.; Lau, C.Y. Transgenic mice expressing the human high-affinity immunoglobulin (Ig) E receptor α chain respond to human IgE in mast cell degranulation and in allergic reactions. J. Exp. Med., 1996, 183(1), 49-56.
[http://dx.doi.org/10.1084/jem.183.1.49] [PMID: 8551243]
[45]
Li, F.; Wang, N.; Yang, Y.; Zhang, S.; Cui, Z.; Zhang, Y.; Liu, Z. Species-specificity in the interaction of IgE with FcεRI between humans and rats. Pharmazie, 2019, 74(1), 29-33.
[PMID: 30782247]
[46]
Hartman, M.L.; Lin, S.Y.; Jouvin, M.H.; Kinet, J.P. Role of the extracellular domain of Fc epsilon RI alpha in intracellular processing and surface expression of the high affinity receptor for IgE Fc epsilon RI. Mol. Immunol., 2008, 45(8), 2307-2311.
[http://dx.doi.org/10.1016/j.molimm.2007.11.017] [PMID: 18179824]
[47]
Mohapatra, S.S.; Qazi, M.; Hellermann, G. Immunotherapy for allergies and asthma: present and future. Curr. Opin. Pharmacol., 2010, 10(3), 276-288.
[http://dx.doi.org/10.1016/j.coph.2010.05.012] [PMID: 20573547]
[48]
Vijayanagar, H.M.; Attallah, N.A.; David, M.F.; Sehon, A.H. Detection of human reagins with rat peritoneal mast cells by histamine release. Int. Arch. Allergy Appl. Immunol., 1974, 46(3), 375-392.
[http://dx.doi.org/10.1159/000231142] [PMID: 4138181]
[49]
Perelmutter, L.; Liakopoulou, A. Detection of IgE mediated immediate hypersensitivity reactions in the sera of ragweed sensitive individuals using rat mast cells. Int. Arch. Allergy Appl. Immunol., 1971, 40(4-5), 481-494.
[http://dx.doi.org/10.1159/000230432] [PMID: 4102841]
[50]
Gillman, S.A.; Haddad, Z.H. Histamine release from rat peritoneal mast cells after passive sensitization with human reaginic serum or E myeloma protein. J. Allergy Clin. Immunol., 1972, 50(3), 131-137.
[http://dx.doi.org/10.1016/0091-6749(72)90043-7] [PMID: 4115105]
[51]
Belostotsky, R.; Lorberboum-Galski, H. Utilizing Fcepsilon-Bak chimeric protein for studying IgE-FcepsilonRI interactions. Clin. Immunol., 2004, 110(1), 89-99.
[http://dx.doi.org/10.1016/j.clim.2003.08.014] [PMID: 14962800]
[52]
Saban, R.; Haak-Frendscho, M.; Zine, M.; Ridgway, J.; Gorman, C.; Presta, L.G.; Bjorling, D.; Saban, M.; Jardieu, P. Human FcERI-IgG and humanized anti-IgE monoclonal antibody MaE11 block passive sensitization of human and rhesus monkey lung. J. Allergy Clin. Immunol., 1994, 94(5), 836-843.
[http://dx.doi.org/10.1016/0091-6749(94)90151-1] [PMID: 7525678]
[53]
Meng, Y.G.; Singh, N.; Wong, W.L. Binding of cynomolgus monkey IgE to a humanized anti-human IgE antibody and human high affinity IgE receptor. Mol. Immunol., 1996, 33(7-8), 635-642.
[http://dx.doi.org/10.1016/0161-5890(96)00024-7] [PMID: 8760275]
[54]
Josephs, D.H.; Spicer, J.F.; Karagiannis, P.; Gould, H.J.; Karagiannis, S.N. IgE immunotherapy: A novel concept with promise for the treatment of cancer. MAbs, 2014, 6(1), 54-72.
[http://dx.doi.org/10.4161/mabs.27029] [PMID: 24423620]
[55]
Leoh, L.S.; Daniels-Wells, T.R.; Penichet, M.L. IgE immunotherapy against cancer. Curr. Top. Microbiol. Immunol., 2015, 388, 109-149.
[http://dx.doi.org/10.1007/978-3-319-13725-4_6] [PMID: 25553797]

Rights & Permissions Print Cite
Article Metrics
34
3
2
1
© 2024 Bentham Science Publishers | Privacy Policy